BLAYNE BAGGETT: Open Payments
NPI 1114382637 · FENTON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 23 payments from 11 companies in 2025. Trend: 2023 $976 · 2024 $1,194 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $98 |
| UCB, Inc. | 3 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| LEO Pharma Inc. | 3 | $56 |
| ABBVIE INC. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Janssen Biotech, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $18 |
Products named: ILUMYA, Bimzelx, COSENTYX, ADBRY, RINVOQ, Sotyktu, TREMFYA, DUPIXENT.
Industry payments across MI — which companies pay providers there.
